Form 8-K MBX Biosciences, Inc. For: Jan 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
MBX Biosciences to present pipeline updates at JP Morgan conference
January 12, 2026 6:05 AM ESTMBX Biosciences Inc. (NASDAQ: MBX) announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026, at 3:45 pm PT. The clinical-stage biopharmaceutical company will provide updates on its clinical programs, obesity pipeline, and 2026 outlook during the presentation.
The company reported that its Phase... More
